🇺🇸 FDA
Pipeline program

Rasagiline

TUD-RaSPar-051

Approved small_molecule completed

Quick answer

Rasagiline for Sleep Disturbances is a Approved program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Sleep Disturbances
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials